局所鎮痛剤の市場規模、シェア、成長分析：治療クラス別、剤形別、性別、年齢層別、タイプ別、流通チャネル別、地域別 - 産業予測 2025～2032年

局所鎮痛剤の世界市場規模は、2023年に112億米ドルと評価され、予測期間（2025-2032年）のCAGR 7.3%で成長し、2024年の120億2,000万米ドルから2032年には211億2,000万米ドルに成長する見通しです。

関節炎の有病率の上昇は、高齢者人口の拡大やアスリート間での使用の増加と並んで、局所鎮痛剤市場の成長を促進する主な要因です。包括的な世界市場レポートによると、関節炎、骨疾患、糖尿病性神経障害、がんに伴う不快感などの症例が増加しているため、この業界は大きな勢いを見せています。局所鎮痛剤製品は、経口薬に比べて副作用が少ないことから支持されています。しかし、潜在的な皮膚刺激や不快な臭いといった課題は、市場の進展を妨げる可能性があります。とはいえ、オンライン流通チャネルの成長と新興国市場の未開発は、市場拡大の有望な機会となっています。このような進化する情勢は、局所鎮痛剤分野の課題と潜在的な成長の道を浮き彫りにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 顧客と購買基準の分析
• 規制分析

局所鎮痛剤市場規模：治療クラス別 & CAGR（2025-2032）

• 市場概要
• 非オピオイド
  • 非ステロイド性抗炎症薬（NSAID）
  • メチルサリチル酸
  • カプサイシン
  • リドカイン
  • その他の非オピオイド
• オピオイド
  • ブプレノルフィン
  • フェンタニル

局所鎮痛剤市場規模：剤形別& CAGR（2025-2032）

• 市場概要
• クリーム
• ゲル
• スプレー
• パッチ
• その他

局所鎮痛剤市場規模：性別& CAGR（2025-2032）

• 市場概要
• 女性
• 男性

局所鎮痛剤市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 成人（18～64歳）
• 高齢者（65歳以上）

局所鎮痛剤市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 処方鎮痛剤
• 市販の鎮痛剤

局所鎮痛剤市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 薬局・ドラッグストア
• 小売店
• オンラインストア

局所鎮痛剤市場規模& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Johnson & Johnson（United States）
• GlaxoSmithKline plc（United Kingdom）
• Novartis AG（Switzerland）
• Pfizer Inc.（United States）
• Reckitt Benckiser Group plc（United Kingdom）
• Sun Pharmaceutical Industries Ltd.（India）
• Endo International plc（Ireland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Sanofi S.A.（France）
• Mylan N.V.（now part of Viatris Inc.）（United States）
• AdvaCare Pharma（United States）
• Topical Biomedics Inc.（United States）

結論と提言

Global Topical Pain Relief Market size was valued at USD 11.2 billion in 2023 and is poised to grow from USD 12.02 billion in 2024 to USD 21.12 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The rising prevalence of arthritis is a key factor driving the growth of the topical pain relief market, alongside an expanding elderly population and increased use among athletes. According to a comprehensive global market report, the industry experiences significant momentum due to rising cases of arthritis, bone disorders, diabetic neuropathy, and cancer-associated discomfort. Topical pain relief products are favored for their reduced side effects compared to oral medications. However, challenges such as potential skin irritation and unpleasant odors could hinder market progress. Nevertheless, the growth of online distribution channels and untapped markets in developing regions present promising opportunities for expansion. This evolving landscape highlights both the challenges and potential avenues for growth in the topical pain relief sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segments Analysis

Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Pain Relief Market

The increasing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, serves as a significant catalyst for the growth of the global topical pain relief market. As more individuals experience these persistent health issues, there is an rising demand for effective, localized pain management options. Consumers are increasingly inclined towards solutions that provide both convenience and targeted relief, which topical treatments can offer. This trend highlights the importance of developing innovative and user-friendly products that cater to the specific needs of patients, driving market expansion and creating opportunities for companies in this sector.

Restraints in the Global Topical Pain Relief Market

Although topical pain relief products are commonly utilized, a significant restraint in the global market lies in the lack of comprehensive clinical evidence supporting their efficacy and safety. This gap in research affects consumer trust and can hinder the widespread adoption of these products. The uncertainty surrounding their performance may lead potential users to seek alternative pain relief options, thereby limiting market growth. Strengthening clinical trials and providing clearer data on the effectiveness and safety profiles of topical pain relief formulations are essential strategies that need to be addressed to enhance consumer confidence and encourage greater market acceptance.

Market Trends of the Global Topical Pain Relief Market

The Global Topical Pain Relief market is experiencing a notable trend towards the use of natural and herbal ingredients in its products, driven by a growing consumer preference for wellness-oriented solutions. As awareness of the potential side effects associated with synthetic components rises, more individuals are seeking topical pain relief options that prioritize natural formulations. This shift is not only indicative of a broader demand for cleaner, greener health products but also reflects an emerging inclination towards holistic approaches to pain management. Consequently, manufacturers are pivoting to incorporate organic, plant-based ingredients, aligning with consumer interests in sustainability and superior health benefits.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Regulatory Analysis

Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2025-2032)

• Market Overview
• Non-opioids
  • Nonsteroidal anti-inflammatory drug (NSAIDS)
  • Methyl salicylates
  • Capsaicin
  • Lidocaine
  • Other non-opioids
• Opioids
  • Buprenorphine
  • Fentanyl

Global Topical Pain Relief Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Cream
• Gel
• Spray
• Patch
• Others

Global Topical Pain Relief Market Size by Gender & CAGR (2025-2032)

• Market Overview
• Women
• Men

Global Topical Pain Relief Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults (18-64 Years)
• Geriatric (65 Years and Above)

Global Topical Pain Relief Market Size by Type & CAGR (2025-2032)

• Market Overview
• Prescription Pain Relief
• Over the Counter (OTC) Pain Relief

Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Pharmacy and Drug Stores
• Retail Stores
• Online Stores

Global Topical Pain Relief Market Size & CAGR (2025-2032)

• North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • US
  • Canada
• Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris Inc.) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AdvaCare Pharma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topical Biomedics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations